![Mark Harvey](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Mark Harvey
Corporate Officer/Principal chez
The University of Queensland
Profil
Mark Harvey is an Adjunct Associate Professor at The University of Queensland.
He previously worked as an Independent Non-Executive Director at Nuwellis, Inc. in 2012, as well as a Director at Pathway Therapeutics, Inc. and Pathway Therapeutics Ltd. He was also a Director at Osprey Medical, Inc. from 2007 to 2011.
Additionally, he served as the Managing Director at Symbiosis Group Ltd. and was a Partner at CM Capital Investments Pty Ltd. from 2010 to 2012.
He was also an Investment Committee Member at ANU Connect Ventures Pty Ltd. Dr. Harvey received his undergraduate, MBA, and doctorate degrees from The University of Queensland.
Postes actifs de Mark Harvey
| Sociétés | Poste | Début |
|---|---|---|
The University of Queensland
 The University of Queensland Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Anciens postes connus de Mark Harvey
| Sociétés | Poste | Fin |
|---|---|---|
CM Capital Investments Pty Ltd.
 CM Capital Investments Pty Ltd. Investment ManagersFinance CM Capital is a hands-on manager which invests in early-stage Australian life sciences (specialty pharmaceuticals, medical devices, drug discovery), telecommunications/IT (mobile telecommunications infrastructure, mobile commerce, data communications, mobile social networking, internet advertising, internet security) and renewable energy companies which can establish market leadership positions in their respective market sectors. The firm seeks to invest AUD 0.5-5 million in companies with talented management, differentiated products with high barriers to entry, products/technology or business models with sustainable competitive advantages, intellectual property owned by the company or in exclusive worldwide use, substantial market opportunities, a clearly defined growth strategy, completed proof of concept and a clear analysis of their market and competitors. CM Capital partners with their investee companies, taking a board seat and providing support including identifying and assisting with recruitment of key employees, board members and strategic advisors, providing introductions to potential customers and strategic partners, working with entrepreneurs to develop their management talents, providing introductions to leading venture capital funds and investment banks, assisting in the development of relationships and strategies to enter global markets and assisting in IPO or M&A transactions. | Director of Investments | 20/11/2012 |
| NUWELLIS, INC. | Directeur/Membre du Conseil | 12/11/2012 |
| OSPY MEDI CDI | Directeur/Membre du Conseil | - |
Symbiosis Group Ltd.
 Symbiosis Group Ltd. Investment ManagersFinance Symbiosis Group invests in private companies located in Australia. The firm focuses on life sciences companies. The firm provides financing for early stage transactions. | Private Equity Investor | 01/04/2006 |
Pathway Therapeutics, Inc.
 Pathway Therapeutics, Inc. BiotechnologyHealth Technology Develops drugs for the treatment of cancer and inflammatory diseases | Directeur/Membre du Conseil | - |
Formation de Mark Harvey
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
46
Relations au 1er degré
8
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 8 |
|---|---|
Nuwellis, Inc.
 Nuwellis, Inc. Medical SpecialtiesHealth Technology Develops heart assist devices | Health Technology |
Pathway Therapeutics, Inc.
Pathway Therapeutics, Inc. BiotechnologyHealth Technology Develops drugs for the treatment of cancer and inflammatory diseases | Health Technology |
CM Capital Investments Pty Ltd.
CM Capital Investments Pty Ltd. Investment ManagersFinance CM Capital is a hands-on manager which invests in early-stage Australian life sciences (specialty pharmaceuticals, medical devices, drug discovery), telecommunications/IT (mobile telecommunications infrastructure, mobile commerce, data communications, mobile social networking, internet advertising, internet security) and renewable energy companies which can establish market leadership positions in their respective market sectors. The firm seeks to invest AUD 0.5-5 million in companies with talented management, differentiated products with high barriers to entry, products/technology or business models with sustainable competitive advantages, intellectual property owned by the company or in exclusive worldwide use, substantial market opportunities, a clearly defined growth strategy, completed proof of concept and a clear analysis of their market and competitors. CM Capital partners with their investee companies, taking a board seat and providing support including identifying and assisting with recruitment of key employees, board members and strategic advisors, providing introductions to potential customers and strategic partners, working with entrepreneurs to develop their management talents, providing introductions to leading venture capital funds and investment banks, assisting in the development of relationships and strategies to enter global markets and assisting in IPO or M&A transactions. | Finance |
The University of Queensland
The University of Queensland Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Pathway Therapeutics Ltd.
 Pathway Therapeutics Ltd. Pharmaceuticals: OtherHealth Technology Develops drugs for the treatment of cancer | Health Technology |
Osprey Medical, Inc.
 Osprey Medical, Inc. Medical SpecialtiesHealth Technology Develops medicine for cardiovascular diseases | Health Technology |
ANU Connect Ventures Pty Ltd.
 ANU Connect Ventures Pty Ltd. Investment ManagersFinance ANU Connect Ventures invest in companies located in Australia. The firm focuses on companies operating in the fields of technology, communication and health technology. It participates in seed and early-stage capital requirements. | Finance |
Symbiosis Group Ltd.
Symbiosis Group Ltd. Investment ManagersFinance Symbiosis Group invests in private companies located in Australia. The firm focuses on life sciences companies. The firm provides financing for early stage transactions. | Finance |
